K2M GROUP HOLDINGS, INC. 4
4 · K2M GROUP HOLDINGS, INC. · Filed Jan 24, 2017
Insider Transaction Report
Form 4
KOSTUIK JOHN PHILIP MD
DirectorChief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2017-01-20−17,284→ 0 totalExercise: $15.00Exp: 2024-05-07→ Common Stock (17,284 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2017-01-20−10,006→ 0 totalExercise: $9.26Exp: 2021-02-26→ Common Stock (10,006 underlying) - Exercise/Conversion
Common Stock
2017-01-20$9.26/sh+10,006$92,656→ 259,113 total - Exercise/Conversion
Common Stock
2017-01-23$23.46/sh+561$13,161→ 249,668 total - Sale
Common Stock
2017-01-23$21.79/sh−561$12,225→ 249,107 total - Sale
Common Stock
2017-01-20$21.61/sh−27,965$604,324→ 249,107 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-01-20−675→ 13,125 totalExercise: $23.46Exp: 2025-07-01→ Common Stock (675 underlying) - Exercise/Conversion
Common Stock
2017-01-20$23.46/sh+675$15,836→ 277,072 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-01-23−561→ 12,564 totalExercise: $23.46Exp: 2025-07-01→ Common Stock (561 underlying) - Exercise/Conversion
Common Stock
2017-01-20$15.00/sh+17,284$259,260→ 276,397 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price in Column 4 is a weighted average. The prices actually received ranged from $21.21 to $21.78. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]An option which is fully vested.
- [F4]An option which vests in three equal installments on July 1, 2016, July 1, 2017 and July 1, 2018.